LOX-1: Implications in atherosclerosis and myocardial ischemia

Authors

  • Tanya Sharma Division of Cardiology, Central Arkansas Veterans Healthcare System and the University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA https://orcid.org/0000-0002-2663-8243
  • Francesco Romeo Department of Cardiology, International University Unicamillus, Rome, Italy https://orcid.org/0000-0002-6176-1159
  • Jawahar L. Mehta Division of Cardiology, Central Arkansas Veterans Healthcare System and the University of Arkansas for Medical Sciences, 4300 W Markham St., Little Rock, AR 72205-4024, USA Tel.: 001-501-296-1426; E-mail: MehtaJL@uams.edu https://orcid.org/0000-0003-0384-2097

DOI:

https://doi.org/10.17179/excli2021-4532

Keywords:

atherosclerosis, myocardial ischemia, oxidized-LDL,, LOX-1

Abstract

Understanding the pathophysiology of atherosclerosis is fundamental to the practice of cardiovascular medicine. Atherosclerosis is a multi-step cascade of accumulation of lipids and downstream changes that lead to a fibro-fatty plaque formation in the arterial intima. Multiple biochemical stimuli, cellular receptors and intra-cellular signals are implicated in this complex mechanism. Lectin-type oxidized LDL receptor-1 or LOX-1 is a type II membrane glycoprotein receptor which has emerged as an important effector of atherosclerosis. Hence, LOX-1 modification and its clinical consequences are of much interest in recent times.

Published

2022-01-13

How to Cite

Sharma, T., Romeo, F., & Mehta, J. L. (2022). LOX-1: Implications in atherosclerosis and myocardial ischemia. EXCLI Journal, 21, 273–278. https://doi.org/10.17179/excli2021-4532

Issue

Section

Review articles